High association of MOG-IgG antibodies in children with bilateral optic neuritis
- PMID: 32327391
- DOI: 10.1016/j.ejpn.2020.04.002
High association of MOG-IgG antibodies in children with bilateral optic neuritis
Erratum in
-
Corrigendum to "High association of MOG-IgG antibodies in children with bilateral optic neuritis" [Eur. J. Paediatr. Neurol. 27 (2020) 86-93].Eur J Paediatr Neurol. 2025 Oct 9:S1090-3798(25)00149-7. doi: 10.1016/j.ejpn.2025.09.006. Online ahead of print. Eur J Paediatr Neurol. 2025. PMID: 41073161 No abstract available.
Abstract
Background: Bilateral optic neuritis (bilON) is a rare clinical presentation often thought to be associated with relapsing disorders such as neuromyelitis optica spectrum disorders (NMOSD) or multiple sclerosis (MS).
Objective: To characterize the clinical, radiological phenotype and antibody status of children presenting with bilON.
Material and methods: Retrospective multicenter study on children with bilON age <18 years with a first episode aquired demyelinating syndrome (ADS), cMRI, AQP4- and serum MOG-antibody status and follow-up data were collected.
Results: 30 patients (f:m = 15:15, median age 8.0y) with bilON met the inclusion criteria. 22/30 (73%) were MOG-positive (median: 1:1280, range: 1:160-1:1520). No patient showed AQP4-abs. 4/30 patients (13%), all with high MOG-abs titers, had recurrent episodes. No patient developed MS. Improvement after IVMP was observed in most patients (26/30; 87%). Outcome was favorable with no sequelae in 22/30 patients. Serial MOG-abs titers tested in 15/22 patients decreased to a median of 1:160 (range: 0-1:640) over a period of 31 months (range: 2-141 months) in 14/15 (93%) patients. MR imaging showed a predominantly anterior affection of the visual system in seropositive patients with bilateral intraorbital lesions in 68% (15/22), compared to 25% in MOG-negative patients (2/8).
Conclusion: Pediatric bilON is associated with high MOG-abs titers in combination with anterior involvement of the visual system. Despite severe loss of vision, the majority of patients shows distinct recovery after IVMP.
Keywords: Antibodies; Autoimmune; Encephalitis; Myelin-oligodendrocyte-glycoprotein.
Copyright © 2020. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of competing interest E. Wendel, M. Baumann, N. Barisic, A. Blaschek, E. Coelho de Oliveira Koch, A. Della Marina, K. Diepold, A. Hackenberg, A. Hahn, T. von Kalle, M. Karenfort, B. Kornek, C. Lechner, S. Leiz, A. Merkenschlager, M. Nosadini, K. Schanda, M. Schimmel, L. Seemann, V. Tüngler, S. Waltz, A. Wegener-Panzer and G. Wiegand have no disclosures. K. Rostásy received speaker's honoraria from Novartis and served on the advisory board of the PARADIGM study. M. Reindl receives payments for antibody assays (MOG, AQP4, and other autoantibodies) and for MOG and AQP4 antibody validation experiments organized by Euroimmun (Lübeck, Germany).
Comment in
-
Myelin-oligodendrocyte-glycoprotein antibody associated disorders (MOGAD): More than meets the eye.Eur J Paediatr Neurol. 2020 Jul;27:2. doi: 10.1016/j.ejpn.2020.06.016. Epub 2020 Jun 29. Eur J Paediatr Neurol. 2020. PMID: 32654920 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous